Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes

L. Pavelka*, A. Rauschenberger, Z. Landoulsi, S. Pachchek, P. May, E. Glaab, R. Krüger, Geeta Acharya, Gloria Aguayo, Myriam Alexandre, Muhammad Ali, Dominic Allen, Wim Ammerlann, Rudi Balling, Michele Bassis, Katy Beaumont, Regina Becker, Camille Bellora, Guy Berchem, Daniela BergAlexandre Bisdorff, Kathrin Brockmann, Jessica Calmes, Lorieza Castillo, Gessica Contesotto, Nico Diederich, Rene Dondelinger, Daniela Esteves, Guy Fagherazzi, Jean Yves Ferrand, Manon Gantenbein, Thomas Gasser, Piotr Gawron, Soumyabrata Ghosh, Enrico Glaab, Clarissa Gomes, Elisa Gómez De Lope, Anne Marie Hanff, Maxime Hansen, Rejko Krüger*, Pauline Lambert, Michel Mittelbronn, Kathleen Mommaerts, Ulf Nehrbass, Sarah Nickels, Laure Pauly, Magali Perquin, Estelle Sandt, Kate Sokolowska, Michel Vaillant, on behalf of the NCER-PD Consortium

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

Fingerprint

Dive into the research topics of 'Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes'. Together they form a unique fingerprint.

Medicine & Life Sciences